Transfusing blood safely and appropriately

BMJ (Online)

Volumn 347, Issue 7917, 2013, Pages

  Murphy, Michael F ^a,b   Waters, Jonathan H ^c   Wood, Erica M ^d   Yazer, Mark H ^e  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d MONASH UNIVERSITY   (Australia)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACTIVATED PROTHROMBIN COMPLEX; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DABIGATRAN; HEMATOLOGIC AGENT; HEMOGLOBIN; HEPARIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROTHROMBIN COMPLEX; RECOMBINANT ACTIVATED FACTOR VII; RIVAROXABAN; TRANEXAMIC ACID; UNCLASSIFIED DRUG; VITAMIN K GROUP; WARFARIN;

ANEMIA; ASYMPTOMATIC DISEASE; BACTERIUM CONTAMINATION; BLEEDING; BLOOD AUTOTRANSFUSION; BLOOD COMPONENT; BLOOD DONOR; BLOOD GROUP ABO SYSTEM; BLOOD GROUP TYPING; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; EMERGENCY CARE; ERYTHROCYTE TRANSFUSION; EVIDENCE BASED MEDICINE; HEMATOLOGIC DISEASE; HEMOSTASIS; HEPATITIS VIRUS; HOSPITAL SERVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INTERNATIONAL NORMALIZED RATIO; INTRAVASCULAR HEMOLYSIS; LABORATORY TEST; NONHUMAN; PATIENT SAFETY; PERIOPERATIVE PERIOD; PHLEBOTOMY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; RISK BENEFIT ANALYSIS; SEPSIS; SEROLOGY; THERAPEUTIC ERROR; THROMBOEMBOLISM; THROMBOSIS; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; VIRAL CONTAMINATION; VIRUS TRANSMISSION;

BLOOD SAFETY; BLOOD TRANSFUSION; HUMANS; RISK FACTORS;

EID: 84880622334     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.f4303     Document Type: Review

References (47)

1. National Blood Authority, Australia. Patient blood management guidelines. www.nba.gov. au/guidelines/review.html.
2. Cochrane Library Special Collection. Avoiding unnecessary transfusion. 2012. www.thecochranelibrary.com/details/collection/2116331/Avoiding- unnecessary-blood-transfusion.html.
3. Hébert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999;340:409-17. (Pubitemid 29084771)
4. Hajjar LA, Vincent JL, Galas FR, Nakamura RE, Silva CM, Santos MH, et al. Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA 2010;304:1559-67.
5. Carson JL, Terrin ML, Noveck H, Sanders DW, Chaitman BR, Rhoads GG, et al; FOCUS Investigators. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med 2011;365:2453-62.
6. Villanueva C, Colomo A, Bosch A, Concepcion M, Hernandez-Gea V, Aracil C, et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med 2013;368:11-21.
7. Goodnough LT, Levy JH, Murphy MF. Current concepts in blood transfusion. Lancet 2013;381:1845-54.
8. Retter A, Wyncoll D, Pearse R, Carson D, McKechnie S, Stanworth S, et al. British Committee for Standards in Haematology. Guidelines on the management of anaemia and red cell transfusion in adult critically ill patients. Br Haematol 2013;160:445-64.
9. Society of Thoracic Surgeons Blood Conservation Guideline Task Force; Ferraris VA, Brown JR, Despotis GJ, Hammon JW, Reece TB, Saha SP, et al. Society of Cardiovascular Anesthesiologists Special Task Force on Blood Transfusion
10. Shore-Lesserson LJ, Goodnough LT, Mazer CD, Shander A, Stafford-Smith M, Waters J. International Consortium for Evidence Based Perfusion
11. Baker RA, Dickinson TA, FitzGerald DJ, Likosky DS, Shann KG. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg 2011;91:944-82.
12. British Committee for Standards in Haematology. Guidelines on oral anticoagulation with warfarin, 4th ed. Br J Haematol 2011;154:311-24.
13. British Committee for Standards in Haematology. Guidelines on the management of bleeding in patients on antithrombotic agents. Br J Haematol 2012;160:35-46.
14. Staves J, Davies A, Kay J, Pearson O, Johnson T, Murphy MF. Electronic remote blood issue: a combination of remote blood issue with a system for end-to-end electronic control of transfusion to provide a "total solution" for a safe and timely hospital blood transfusion service. Transfusion 2008;48:415-24. (Pubitemid 351294568)
15. Radkay L, Triulzi DJ, Yazer MH. Low risk of hemolysis following transfusion of uncrossmatched RBCs. Immunohematology 2012;28:39-44.
16. Goodell PP, Uhl L, Mohammed M, Powers AA. Risk of hemolytic transfusion reactions following emergency-release RBC transfusion. Am J Clin Pathol 2010;134:202-6.
17. Harm SK, Delaney M, Charapata M, AuBuchon JP, Triulzi DJ, Yazer MH. Routine use of a rapid test to detect bacteria at the time of issue for non-leukoreduced, whole blood-derived platelets. Transfusion [forthcoming].
18. Jacobs MR, Smith D, Heaton WA, Zantek ND, Good CE. Detection of bacterial contamination in prestorage culture negative apheresis platelets on day of issue with the Pan Genera Detection test. Transfusion 2011;51:2573-82.
19. Serious Hazards of Transfusion (SHOT) scheme. Annual SHOT report 2011. www.shotuk. org/shot-reports/shot-annual-report-summary-2011/
20. Turner CL, Casbard AC, Murphy MF. Barcode technology: its role in increasing the safety of blood transfusion. Transfusion 2003;43:1200-9. (Pubitemid 37082679)
21. Chan JC, Chu RW, Young BW, Chan F, Chow CC, Pang WC, et al. Use of an electronic barcode system for patient identification during blood transfusion: 3-year experience in a regional hospital. Hong Kong Acad Med 2004;10:166-71. (Pubitemid 38788621)
22. Askeland RW, McGrane S, Levitt JS, Dane SK, Greene DL, Vandeberg JA, et al. Improving transfusion safety: implementation of a comprehensive computerized bar code-based tracking system for detecting and preventing errors. Transfusion 2008;48:1308-17.
23. Murphy MF, Casbard AC, Ballard S, Shulman IA, Heddle N, Aubuchon JP, et al. Prevention of bedside errors in transfusion medicine (PROBE-TM) study: a cluster-randomized, matched-paired clinical areas trial of a simple intervention to reduce errors in the pretransfusion bedside check. Transfusion 2007;47:771-80. (Pubitemid 46668989)
24. Murphy MF, Staves J, Davies A, Fraser E, Parker R, Cripps B, et al. How do we approach a major change program using the example of the development, evaluation, and implementation of an electronic transfusion management system. Transfusion 2009;49:829-37.
25. Murphy MF, Fraser E, Miles D, Noel S, Staves J, Cripps B, et al. How do we monitor hospital transfusion practice using an end-to-end electronic transfusion management system? Transfusion 2012;52:2502-12.
26. Oxford University Hospitals. Electronic blood transfusion: improving safety and efficiency of transfusion systems. NHS Evidence QIPP. 2013. https://www.evidence.nhs.uk/qipp/recommended/search?am=[{%22srn%22: [%22%20qipp%20%22]}]&fs=qippcat. RecommendedReading.
27. Murphy MF, Little T. A survey of hospital blood transfusion laboratory information technology systems and their functionality. Transfus Med 2008;18:204-6. (Pubitemid 351847327)
28. Little T, Murphy MF. Survey of IT systems in hospital transfusion laboratories. 2011. www.transfusionguidelines.org.uk/docs/pdfs/nbtc-bbt-survey- it-2011v2.pdf.
29. British Committee for Standards in Haematology. Guideline on the investigation acute transfusion reactions. Br J Haematol 2012;159:143-53.
30. Dzik WH, Murphy MF, Andreu G, Heddle N, Hogman C, Kekomaki R, et al. An international study of the performance of blood sample collection. Vox Sang 2003;85:40-7. (Pubitemid 36827949)
31. Murphy MF, Stearn BE, Dzik WH. Current performance of patient sample collection in the UK. Transfus Med 2004;14:113-21. (Pubitemid 38623074)
32. Department of Health. Health service circular on better blood transfusion: safe and appropriate use of blood. HSC 2007/001. 2007. www.transfusionguidelines.org.uk/docs/pdfs/nbtc-bbt-hsc-07.pdf.
33. NHS Blood and Transplant. National comparative audit of blood transfusion. http://hospital. blood.co.uk/safe-use/clinical-audit/National- Comparative/index.asp.
34. Murphy MF, Stanworth SJ, Yazer M. Transfusion practice and safety: current status and possibilities for improvement. Vox Sang 2011;100:46-59.
35. Hunt DL, Haynes RB, Hanna SE, Smith K. Effects of computer-based clinical decision support systems on physician performance and patient outcomes: a systematic review. JAMA 1998;280:1339-46. (Pubitemid 28473723)
36. Kawamoto K, Houlihan CA, Balas EA, Lobach DF. Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success. BMJ 2005;330:765.
37. Garg AX, Adhikari NK, McDonald H, Rosas-Arellano MP, Devereaux PJ, Beyene J, et al. Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: a systematic review. JAMA 2005;293:1223-38. (Pubitemid 40327908)
38. Yazer MH, Waters JH. How do I ... Implement a blood management program? Transfusion 2012;52:1640-5.
39. Rothschild JM, McGurk S, Honour M, Lu L, McClendon AA, Srivastava P, et al. Assessment of education and computerized decision support interventions for improving transfusion practice. Transfusion 2007;47:228-39. (Pubitemid 46146556)
40. Yazer MH, Triulzi DJ, Reddy V, Waters JH. Effectiveness of a real-time clinical decision support system for computerized physician order entry of plasma orders. Transfusion 2013; published online 2013 30 Apr.
41. Waters JH, Dyga RM, Yazer MH. The volume of returned RBCs in a large blood salvage program: where does it all go? Transfusion 2011;51:2126-32.
42. Waters JH, Yazer MH, Chen Y-F, Kloke J. Blood salvage and cancer surgery: a meta-analysis of available studies. Transfusion 2012; published online 31 Aug.
43. Afshari A, Wikkelsø A, Brok J, Møller AM, Wetterslev J. Thrombelastography (TEG) or thromboelastometry (ROTEM) to monitor haemotherapy versus usual care in patients with massive transfusion. Cochrane Database Syst Rev 2011;3:CD007871.
44. CRASH-2 collaborators; Roberts I, Shakur H, Afolabi A, Brohi K, Coats T, Dewan Y, et al. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet 2011;377:1096-101.
45. Perel P, Al-Shahi Salman R, Kawahara T, Morris Z, Prieto-Merino D, Roberts I, et al. CRASH-2 (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage) intracranial bleeding study: the effect of tranexamic acid in traumatic brain injury-a nested randomised, placebo-controlled trial. Health Technol Assess 2012;16:iii-xii, 1-54.
46. Wong J, Abrishami A, El Beheiry H, Mahomed NN, Davey JR, Gandhi R, et al. Loss in total knee arthroplasty: a randomized, controlled trial. Topical application of tranexamic acid reduces postoperative blood. J Bone Joint Surg Am 2010;92:2503-13.
47. Ker K, Roberts I, Perel P, Edwards P, Shakur H. Tranexamic acid for surgical bleeding: A systematic review and cumulative meta-analysis. BMJ 2012;344:e3504.